HELXFranklin Genomic Advancements ETF

Grow my money#1953 of 2944 for Grow my money

Capital appreciation.

Franklin Templeton Investments · Since 2020 (6 years)

Annual Cost

0.50%

#2384 out of 5,332 ETFs

Fund Size

$21M

#4053 out of 5,332 ETFs

Dividend Yield

0.43%

Track Record

6 years

#2098 out of 5,332 ETFs

Performance

1 Year

+23.1%

3 Years

+4.5%

5 Years

-6.8%

What's inside

Asset class

equity

Strategy

index tracking

Cap

multi cap

Sector

health care

Focus

Biotech & Genomics

Asset allocation

Stocks

96.9%

Cash

3.1%

Sector breakdown

Healthcare

96.5%

Basic Materials

2.8%

Technology

0.7%

Top holdings

Guardant Health IncGH6.8%

Natera IncNTRA6.6%

Krystal Biotech IncKRYS5.3%

United Therapeutics CorpUTHR4.6%

Insmed IncINSM4.5%

BridgeBio Pharma IncBBIO4.2%

Ligand Pharmaceuticals IncLGND3.5%

AstraZeneca PLCAZN.L3.4%

Adaptive Biotechnologies CorpADPT3.1%

Vertex Pharmaceuticals IncVRTX3.0%

Risk profile

Volatility (1Y)

21.3%

High

Max drawdown

-58.7%

Worst peak-to-trough loss

Sharpe (3Y)

0.15

Below average

Sortino (3Y)

0.21

Moderate downside risk

Similar ETFs

IQM

Franklin Intelligent Machines ETF

TER 0.50%3Y +37.9%

Grow my money

XDAT

Franklin Exponential Data ETF

TER 0.50%3Y +12.8%

Grow my money

FLHY

Franklin High Yield Corporate ETF

TER 0.40%3Y +9.5%

Get income

Data updated on 2026-05-05